/Companies

Mitochon Pharmaceuticals

Radnor, US · Founded 2014 · Delaware corporation · 1 known investors

Find your way into Mitochon Pharmaceuticals

Sign up to see every warm intro you have to Mitochon Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Mitochon Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Mitochon is an early-stage biopharmaceutical company developing therapeutics. The page does not provide details about specific products, target indications, or customer segments beyond the biopharmaceutical sector.

Founders & leadership

Mitochon Pharmaceuticals was founded in 2014 by John G. Geisler.

JGJohn G. Geisler
John G. GeislerFounder & Chief Scientific OfficerJohn G. Geisler is Founder and Chief Scientific Officer of Mitochon Pharmaceuticals, a biopharmaceutical company developing therapeutics targeting mitochondrial dysfunction. With over 25 years of experience in drug discovery, pharmacology, physiology, and mammalian genetics, he has worked on treatments for metabolic, neurodegenerative, and neuromuscular diseases, and launched Mitochon in 2014 to investigate mitochondrial-targeted approaches for neurodegeneration, autoimmune, neuromuscular, and developmental disorders.
PC
Peter CrooksExecutive
RARobert Alonso
Robert AlonsoChief Executive Officer and FounderRobert Alonso brings 25 years of pharmaceutical and biotechnology experience across both large multinational corporations and early-stage companies, with expertise in capital raising, therapeutic development from preclinical through regulatory approval, and drug commercialization. As founder and CEO of Mitochon Pharmaceuticals, he has previously led company formation, business development, and international operations in the US and Europe.

Board

JI
John IrwinBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$825K disclosed across 2 rounds · 2014–2016

▶$425KraisedApr 2016 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John IrwinDirector
  • Peter CrooksExecutive Officer
  • John GeislerExecutive Officer, Director
  • Robert AlonsoExecutive Officer, Director
Offering amount
$700K
Amount sold
$425K
Minimum investment
$25K
Proceeds to insiders
$6K
First sale
Apr 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedDec 2014 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John IrwinDirector
  • Peter CrooksExecutive Officer
  • Robert AlonsoExecutive Officer, Director
  • John GeislerExecutive Officer, Director
Offering amount
$750K
Amount sold
$400K
Minimum investment
$25K
Proceeds to insiders
$6K
First sale
Nov 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does Mitochon Pharmaceuticals do?
Mitochon is an early-stage biopharmaceutical company developing therapeutics. The page does not provide details about specific products, target indications, or customer segments beyond the biopharmaceutical sector.
Who founded Mitochon Pharmaceuticals?
Mitochon Pharmaceuticals was founded by John G. Geisler in 2014.
Who are Mitochon Pharmaceuticals's investors?
Mitochon Pharmaceuticals's investors include Ben Franklin Technology Partners.
How much funding has Mitochon Pharmaceuticals raised?
Mitochon Pharmaceuticals has disclosed $825K raised across 2 rounds.
Where is Mitochon Pharmaceuticals headquartered?
Mitochon Pharmaceuticals is headquartered in Radnor, US.